Import Blood Glucose Monitoring System — Buy in Bulk from Supplier in China

The blood glucose monitoring system from Minkang Medical Technology (Tianjin) Co., Ltd. measures glucose across a range of 20 to 600 mg/dl, equivalent to 1.1 to 33.3 mmol/l, which covers hypoglycaemic through severely hyperglycaemic states. The unit requires a minimal blood sample of 0.7 microliters, drawn as fresh capillary whole blood. Results are delivered within seconds, positioning it for point-of-care and self-monitoring use cases. The system is intended for professional healthcare settings and individual patient management alike.

The device operates on electrochemical biosensor technology, a standard approach in contemporary glucometers, where glucose oxidase or dehydrogenase reactions generate a current proportional to blood glucose concentration. A 0.7 microliter sample volume is below the historical 1.0 microliter threshold, reducing patient discomfort and improving compliance for frequent testers. The 20 to 600 mg/dl span aligns with clinical requirements for detecting both insulin overdose and diabetic ketoacidosis scenarios. Memory capacity and data port specifications are not stated in the source materials. Typical systems in this class store 300 to 1,000 readings with time/date stamps; buyers should confirm this unit's exact logging capability.

Primary buyers include hospitals, outpatient clinics, retail pharmacies, and direct consumers managing diabetes at home. The compact form factor supports bedside testing, home health visits, and patient self-management programmes. Importers serving these channels should verify whether the unit ships with lancing devices, control solution, and carrying cases as standard or optional. Calibration coding (manual vs. automatic), strip stability (typical: 18 to 24 months unopened), and altitude or haematocrit interference data should be requested from Minkang Medical Technology directly, as these determine suitability for regional distribution.

Minkang Medical Technology (Tianjin) Co., Ltd. is located at Building 17, No. 80 Haiyun Street, Binhai Development Zone, Tianjin 300457, China. The Binhai Development Zone is a state-level economic and technological development area, which hosts pharmaceutical and medical device manufacturing clusters. The supplier holds an imported tier designation and a harbor trust tier. The response rate is recorded at 0.00 percent, with zero average response hours logged. These signals suggest limited or no active engagement through the platform channel at present.

The listing positions the blood glucose monitoring system for hospital, clinic, pharmacy, and home healthcare applications. No manufacturing certifications (ISO 13485, CE, FDA), production capacity figures, year of establishment, or staff numbers are stated in the source profile. Buyers should request a current quality management system certificate, product registration status for target markets, and factory audit reports before committing to volume orders. Direct outreach to the Tianjin address is advisable, given the absence of platform response data.